In Session
NDIs Political Reality

A new political landscape for NDIs sparks questions about regulation

With the appointment of a new FDA commissioner, regulations for NDIs could shift. This session at Natural Products Expo West 2017 features three expert perspectives on the current state of regulations in the U.S. and the potential impacts in the coming years.

"We need to be the leaders, not only in terms of responsibility, but ethics. This post-regulatory age is an opportunity to display our ethics."

—Scott Steinford, Trust Transparency Consulting

Part 1: Introduction by Rick Polito 

Highlights:

  • Is the industry in a post-regulatory age? 

-----

Part 2: FDA enforcement 

Highlights: 

  • Larisa Pavlick, United Natural Products Alliance, details FDA enforcement strategies.
  • Three different categories for FDA enforcement.  

-----

Part 3: Risk assessment

Highlights: 

  • Ashish Talati, Amin Talati & Upadhye, shares his risk-based analysis model. 
  • Detailed risk levels and what to do when ingredients meet certain specifications. 

-----

Part 4: The cat and mouse game

Highlights:

  • Scott Steinford of Trust Transparency Consulting addresses the need for manufacturers and businesses to be "self-policing."
  • The intent behind NDI regulation.


-----

Part 5: Questions and answers

Highlights:

  • Forecasting the future of regulations with the new FDA commissioner.
  • The consumer demand for compliance and transparency.

 

This session—NDIs & the New Political Reality, What to Expect in the Post-Regulatory Age—was recorded at Natural Products Expo West 2017.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish